GW Pharmaceuticals PLC (NASDAQ:GWPH)

122.93
Delayed Data
As of May 29
 -2.53 / -2.02%
Today’s Change
67.98
Today|||52-Week Range
182.05
+17.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues44.0M14.6M10.4M15.5M
 
 
 
 
 
Cost of Goods Sold3.9M3.8M4.5M6.3M
 
 
 
 
 
Depreciation And Amortization3.5M5.2M7.0M9.4M
 
 
 
 
 
 
Operating ExpensesGross Income36.6M5.6M-1.0M-211.6K
 
 
 
 
 
General Expenses133.5M164.1M186.2M273.9M
 
 
 
 
 
Research And Development114.1M141.1M140.9M133.5M
 
 
 
 
 
Total Operating Expenses140.9M173.2M197.7M289.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-96.9M-158.6M-187.2M-274.1M
 
 
 
 
 
Extraordinary Charge-934.5K0.00-530.8K0.00
 
 
 
Interest Expense On Debt115.7K244.6K943.7K1.3M
 
 
 
 
 
Other Expenses9.6M36.1M-6.4M-2.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-88.0M-121.8M-193.1M-268.6M
 
 
 
 
 
Income Taxes-19.3M-31.8M-26.2M-4.1M
 
 
 
 
 
Net Income-68.7M-90.0M-166.8M-272.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS20.5M22.5M25.3M28.4M
 
 
 
 
 
Shares To Calculate EPS Diluted20.5M22.5M25.3M28.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.35-$3.99-$6.60-$9.61
 
 
 
 
 
EPS Diluted-$3.35-$3.99-$6.60-$9.61